Pinetree Therapeutics, a preclinical-stage biotechnology company pioneering targeted protein degraders for drug-resistant cancers, announced the successful closing of an oversubscribed $47 million ...
UCSF researchers and clinicians presented innovative research and treatment strategies at the American Society of Radiation Oncology’s 2025 Annual Meeting in San Francisco, which ran from Sept. 27 to ...
These cases illustrate scenarios where final pathology often reveals a higher risk of recurrence than anticipated, requiring ...
At the ESMO Annual Meeting 2025, experts urge governments to make workforce training a political priority, calling it key to ...
Total revenues of $1.37 billion in the third quarter of 2025, reflecting 20% growth compared to the third quarter of 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback